Clinical Trials on Critical Care in New Zealand

Total 19622 results

National Medical Research Council (NMRC), Singapore

Completed

Tamoxifen in Treating Patients With Primary Liver Cancer

Liver Cancer

New Zealand, Hong Kong, Indonesia, Malaysia, Pakistan, Singapore
Gilead Sciences

Completed

Pharmacokinetics and Pharmacodynamics of Cilofexor in Adults With Normal and Impaired Hepatic Function

Nonalcoholic Steatohepatitis (NASH) | Primary Sclerosing Cholangitis (PSC)

United States, New Zealand
Rutgers, The State University of New Jersey
National Cancer Institute (NCI)

Active, not recruiting

Swallowing Outcomes and Circulating Tumor DNA in Patients With HPV Related Oropharyngeal Cancer Treated With Transoral Surgery and Reduced Intensity Adjuvant Therapy

Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Oropharyngeal Human Papillomavirus-Positive Squamous...

United States
AnGes USA, Inc.

Completed

A Phase IIB Pilot Study of a Modified Dosage Regimen of AMG0001 in Subjects With Critical Limb Ischemia

Vascular Diseases | Peripheral Arterial Disease | Critical Limb Ischemia

United States
Zealand University Hospital
University of Copenhagen; Technical University of Denmark; OptoCeutics

Completed

Study on Safety, Feasibility and Neural Activation of Non-Invasive Light Therapy System (ALZLIGHT Pilot)

Alzheimer Disease

Denmark
GlaxoSmithKline

Completed

Study Of Eltrombopag in Healthy Subjects and Volunteers With Mild, Moderate or Severe Hepatic Impairment

Purpura, Thrombocytopaenic, Idiopathic

United States, Australia, New Zealand
Rijnstate Hospital
W.L.Gore & Associates

Active, not recruiting

Iliac Branch Excluder ReGistry (IceBERG) (IceBERG)

Aneurysm | Abdominal Aortic Aneurysms | Common Iliac Aneurysms

Italy, New Zealand, Netherlands, Spain
Alios Biopharma Inc.
Vertex Pharmaceuticals Incorporated

Terminated

First in Human Study of ALS-002158; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C Genotype 1

Hepatitis C, Chronic

Australia, New Zealand
Pharmaxis

Completed

A Phase 2 Study to Determine the Safety and Efficacy of Inhaled Dry Powder Mannitol in Cystic Fibrosis

Cystic Fibrosis

Australia, New Zealand
University of Copenhagen
Bispebjerg Hospital; Lundbeck Foundation; Region Capital Denmark; Bevica Fonden; Danish... and other collaborators

Completed

Electrical Stimulation of the Paretic Upper Limb in the Early Stroke Phase

Stroke, Acute

Denmark
Indian Society of Critical Care Medicine

Completed

Second Survey of Intensive Care in India (INDICAPS-II)

Critical Illness

India
Hoffmann-La Roche

Completed

A Study of Early Immunologic Response in Asian Patients With Chronic Hepatitis B, Treated With Pegasys (Peginterferon Alfa-2a (40KD)), Nucleoside Analogues, or Both

Hepatitis B, Chronic

Taiwan, United States, New Zealand, Singapore
Hoffmann-La Roche

Completed

A Study of Pegasys Monotherapy in Patients With Chronic Hepatitis B Who Have Participated in Previous Studies

Hepatitis B, Chronic

Taiwan, United States, New Zealand, Singapore
Gilead Sciences

Completed

Study to Evaluate the Pharmacokinetics of Tenofovir Alafenamide (TAF) in Adults With Normal Hepatic Function and Adults With Severe Hepatic Impairment

Hepatitis B Virus

United States, Germany, New Zealand
Alexion Pharmaceuticals
Achillion, a wholly owned subsidiary of Alexion

Completed

Study of Danicopan in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH)

Paroxysmal Nocturnal Hemoglobinuria (PNH)

United Kingdom, New Zealand, Korea, Republic of, Italy
Dartmouth-Hitchcock Medical Center

Recruiting

Gastric US in ICU Patient

Critical Illness | Surgery | Aspiration Pneumonia

United States
Bristol-Myers Squibb

Terminated

A Study Evaluating the Drug Levels of Iplimumab Given Under the Skin Alone and in Combination With Nivolumab in Multiple Tumor Types (CheckMate 76U)

Tumor

Italy, United States, New Zealand
Pfizer

Terminated

A First in HumanTrial to Evaluate The Safety, Tolerability, And Pharmacokinetics Of PF-06755347

Healthy | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | Primary Immune Thrombocytopenia

Spain, United States, Belgium, United Kingdom, New Zealand
Arrowhead Pharmaceuticals

Completed

Study of ARO-HBV in Normal Adult Volunteers and Patients With Hepatitis B Virus (HBV)

Hepatitis B

Australia, Hong Kong, New Zealand
GlaxoSmithKline

Completed

Prednisolone Novel Endpoint Study in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive

Argentina, Chile, South Africa, New Zealand
Denver Health and Hospital Authority
National Trauma Research Institute

Completed

IV Iron for the Anemia of Traumatic Critical Illness (IATCI)

Trauma | ICU Anemia

United States
Bayer

Completed

A Manufacturing Transfer Study Comparing the Bioequivalence of a Single Oral Dose of Claritin-D 12-Hour Extended Release Tablet From 2 Different Manufactuers Under Fed Conditions in Healthy Adult Subjects

Clinical Pharmacology

United States
University of British Columbia

Completed

Predicting Complications in Women With Toxaemia

Toxemia

United Kingdom, Canada, New Zealand
Yale University
University Hospitals Cleveland Medical Center; Shockwave Medical, Inc.

Recruiting

CRUSH PAD: Real-world Outcomes Following Use of the Shockwave Intravascular Lithotripsy (IVL) Technology in Calcified Common Femoral Lesions

Peripheral Arterial Disease | Claudication | Critical Limb Ischemia | Femoral Arterial Calcification

United States
NYU Langone Health
National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...

Completed

Platelet Activity in Vascular Surgery and Cardiovascular Events (PACE)

Cardiovascular Disease | Peripheral Artery Disease | Critical Limb Ischemia

United States
NYU Langone Health

Withdrawn

Inflammation in Type 2 Myocardial Infarction

Myocardial Infarction | Inflammation | Critical Illness

United States
AzurRx SAS

Completed

A Phase IIa Study With Escalating Dose of MS1819-SD

Chronic Pancreatitis | Distal Pancreatectomy

Australia, New Zealand, France
The Mind Research Network

Recruiting

Neurocognitive Abnormalities in Stimulant Abuse Among High-Risk Women

Criminal Behavior | Stimulant Abuse

United States
Trek Therapeutics, PBC

Completed

A Study of Faldaprevir, TD-6450 and Other Antivirals in Participants With Genotype 1b Hepatitis C Virus Infection

Chronic Hepatitis C | Hepatitis C Genotype 1 | Hepatitis C (HCV) | Hepatitis C Viral Infection

United States, New Zealand
Azienda Usl di Bologna

Recruiting

Prehospital Management of Hypotensive Trauma in HEMS (SPITFIRE)

Wounds and Injuries | Emergencies | Critical Care | Hypotension and Shock

Italy
Icahn School of Medicine at Mount Sinai

Completed

Realtime Streaming Clinical Use Engine for Medical Escalation (ReSCUE-ME)

Monitoring, Physiologic | Clinical Deterioration | Hospital Medicine

United States
Slagelse Hospital
Odense University Hospital; Zealand University Hospital; Hvidovre University... and other collaborators

Completed

Monitoring Patients With Shortness of Breath With Repeated Ultrasound Examinations (MODUS)

Dyspnea

Denmark
The University of Queensland
Telethon Kids Institute

Completed

Prevention of Bronchiectasis in Infants With Cystic Fibrosis (COMBATCF)

Bronchiectasis | Cystic Fibrosis

Australia, New Zealand
Roswell Park Cancer Institute
National Comprehensive Cancer Network

Active, not recruiting

Use of Trifluridine/Tipiracil and Oxaliplatin as Induction Chemotherapy for the Treatment of Resectable Esophageal or Gastroesophageal Junction (GEJ) Adenocarcinoma

Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 | Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8 | Clinical Stage III Esophageal Adenocarcinoma AJCC v8 | Clinical Stage IVA Esophageal Adenocarcinoma AJCC v8 | Pathologic Stage IIB Esophageal Adenocarcinoma AJCC v8 | Pathologic Stage III Esophageal Adenocarcinoma AJCC v8 and other conditions

United States
ReCode Therapeutics

Recruiting

Study Evaluating the Safety and Tolerability of RCT1100 in Healthy and PCD Subjects

Primary Ciliary Dyskinesia

United Kingdom, United States, Australia, New Zealand
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Delanzomib (CEP-18770) in Combination With Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma

Multiple Myeloma

United States, New Zealand
Critical Care Pharmacotherapy Trials Network
University of Arkansas

Completed

Drug Resistance Factors In Healthcare-associated Pneumonia (DEFINE)

Pneumonia | Critical Illness

United States, Saudi Arabia
Children's Oncology Group
National Cancer Institute (NCI); Pediatric Brain Tumor Consortium

Active, not recruiting

Pilot Study to Enable Electronic Laboratory Data Transfer From Participating Institutions to MediData/RAVE

Accurate and Complete Data Acquisition for Clinical Trials

United States
Ionis Pharmaceuticals, Inc.

Active, not recruiting

A Study to Evaluate the Effectiveness and Safety of IONIS-FB-LRx, an Antisense Inhibitor of Complement Factor B, in Adult Participants With Primary IgA Nephropathy

Primary IgA Nephropathy

Canada, Australia, New Zealand, Singapore
Kirby Institute
AbbVie

Completed

Treatment of Recently Acquired Hepatitis C With the 3D Regimen or G/P (TARGET3D)

Hepatitis C, Acute

United Kingdom, Australia, New Zealand
Baxalta now part of Shire

Completed

Efficacy and Safety Study of Augmentation Therapy With ARALAST Fraction IV-1 (Human Alpha 1 - Proteinase Inhibitor)

Alpha 1-Antitrypsin Deficiency

New Zealand, Australia
Abbott Medical Devices

Completed

Complete Lesion Assessment With ffR and IVUS TechnologY (CLARITY I)

Peripheral Artery Disease | Critical Limb Ischemia

United States
Janssen Pharmaceutica N.V., Belgium

Completed

A Study to Evaluate the Efficacy and Safety of Sirukumab in Confirmed Severe or Critical Confirmed Coronavirus Disease (COVID)-19

Critical Confirmed Coronavirus Disease (COVID)-19

United States
Zhejiang Medicine Co., Ltd.
Ambrx, Inc.

Terminated

A Dose-escalation Study of ARX788, IV Administered in Subjects With Advanced Cancers With HER2 Expression

Stomach Neoplasms | Breast Neoplasms

Australia, New Zealand
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

Glutamate Reducing Interventions in Schizophrenia

Clinical High Risk for Psychosis

United States
National Cancer Institute (NCI)

Suspended

Nivolumab and Ipilimumab in Treating Patients With Esophageal and Gastroesophageal Junction Adenocarcinoma Undergoing Surgery

Esophageal Adenocarcinoma | Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 | Gastroesophageal Junction Adenocarcinoma | Clinical Stage II Esophageal Adenocarcinoma AJCC v8 | Clinical Stage III Esophageal Adenocarcinoma AJCC v8 | Clinical Stage IVA Esophageal Adenocarcinoma... and other conditions

United States
NeuroActiva, Inc.
Biomed Industries, Inc.

Unknown

A Phase 3 Randomized Double Blind Efficacy and Safety Study of Oral Polio Vaccine and NA-831 for Covid-19 (OPV-NA831)

Covid19 | SARS-CoV-2 | SARS-CoV Infection | SARS (Severe Acute Respiratory Syndrome)

New Zealand, United States
Edwards Lifesciences

Completed

THE PARTNER TRIAL: Placement of AoRTic TraNscathetER Valve Trial (PARTNER)

Critical Aortic Stenosis

United States, Canada, Germany
Alere San Diego

Completed

Heart Failure (HF) Outpatient Monitoring Evaluation (HOME) Study (HOME)

Heart Failure | Acute Decompensated Heart Failure | Systolic Heart Failure

United Kingdom, Australia, New Zealand, Sweden, Ireland, Netherlands
Endologix

Active, not recruiting

Nellix Registry Study: EVAS-Global (EVAS FORWARD 2)

Abdominal Aortic Aneurysm

New Zealand, Spain, Germany, Netherlands

Clinical Trials on Critical Care in New Zealand

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Taiwan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations